Heart failure and iron deficiency anemia in Italy: results from CARMES-1 registry.
暂无分享,去创建一个
M. C. Gatto | F. Fedele | M. Mancone | G. Ansalone | E. Canali | R. di Pietro | M. Pagliaro | C. Caira | L. Fratarcangeli | Ca Centurion Aznaran | M. Gatto | R. Di Pietro
[1] Feng Liu,et al. A systematic review and meta-analysis 2 , 2015 .
[2] Juerg Schwitter,et al. Corrigendum to: ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012’[Eur Heart J 2012;33:1787–1847, doi:10.1093/eurheartj/ehs104 , 2013 .
[3] Juerg Schwitter,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.
[4] P. Ponikowski,et al. Iron deficiency: an ominous sign in patients with systolic chronic heart failure. , 2010, European heart journal.
[5] G. Bailie,et al. Safety and tolerability of intravenous ferric carboxymaltose in patients with iron deficiency anemia , 2010, Hemodialysis international. International Symposium on Home Hemodialysis.
[6] P. Ponikowski,et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. , 2009, The New England journal of medicine.
[7] H. Hillege,et al. Anemia and mortality in heart failure patients a systematic review and meta-analysis. , 2008, Journal of the American College of Cardiology.
[8] G. Filippatos,et al. Effects of darbepoetin-alpha on quality of life and emotional stress in anemic patients with chronic heart failure , 2008, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[9] G. Filippatos,et al. Effects of darbepoetin alpha on right and left ventricular systolic and diastolic function in anemic patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. , 2008, American heart journal.
[10] P. Armstrong,et al. Randomized Double-Blind Trial of Darbepoetin Alfa in Patients With Symptomatic Heart Failure and Anemia , 2008, Circulation.
[11] P. Ponikowski,et al. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. , 2007, Journal of the American College of Cardiology.
[12] P. Ponikowski,et al. Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia. , 2008, European heart journal.
[13] P. Duarte,et al. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. , 2007, Journal of the American College of Cardiology.
[14] D. Karageorgopoulos,et al. Etiology of anemia in patients with advanced heart failure. , 2006, Journal of the American College of Cardiology.
[15] S. Katz,et al. Anemia in Chronic Heart Failure: Prevalence, Etiology, Clinical Correlates, and Treatment Options , 2006, Circulation.
[16] L. Tavazzi,et al. Nationwide survey on acute heart failure in cardiology ward services in Italy. , 2005, European heart journal.
[17] Luigi Tavazzi,et al. Acute Heart Failure Syndromes: Current State and Framework for Future Research , 2005, Circulation.
[18] K. Adams,et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). , 2005, American heart journal.
[19] J. McMurray,et al. Anemia and Its Relationship to Clinical Outcome in Heart Failure , 2004, Circulation.
[20] L. Tavazzi,et al. Current presentation and management of heart failure in cardiology and internal medicine hospital units: a tale of two worlds--the TEMISTOCLE study. , 2003, American heart journal.
[21] N Freemantle,et al. The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. , 2003, European heart journal.
[22] I. Shapira,et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. , 2000, Journal of the American College of Cardiology.